Severe renal impairment during triple therapy with telaprevir

Clin Res Hepatol Gastroenterol. 2014 Sep;38(4):e69-71. doi: 10.1016/j.clinre.2013.12.005. Epub 2014 Jan 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Female
  • Hepatitis C / drug therapy
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Middle Aged
  • Oligopeptides / adverse effects*
  • Oligopeptides / therapeutic use
  • Polyethylene Glycols / adverse effects*
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use
  • Severity of Illness Index

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Oligopeptides
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • telaprevir
  • peginterferon alfa-2a